Press Releases - 2006
December 20, 2006 Record influenza vaccine production capabilities strengthen sanofi pasteur’s global leadership and place the company at the forefront of pandemic readiness
More
November 27, 2006 Sanofi Pasteur Completes Shipment of 50 Million Doses of Influenza Vaccine November 20, 2006
Sanofi Pasteur Signs Contract with U.S. Government for Stockpile of New Type of H5N1 Pre-Pandemic Vaccine October 12, 2006
Sanofi Pasteur on Track to Deliver 50 Million Doses of Influenza Vaccine to U.S. Market.
MoreSeptember 29, 2006
Sanofi Pasteur and the Pediatric Dengue Vaccine Initiative Partner Against Dengue Fever September 26, 2006 - Sanofi pasteur initiated its first clinical study with influenza vaccine produced using cell culture technology. September 1, 2006
Sanofi Pasteur Begins Shipment of Influenza Vaccine February 6, 2006 – Sanofi pasteur delivers more H5N1 vaccine to the U.S. government, including investigational doses formulated with an adjuvant. February 1, 2006 - Immunization providers contacted the company in record numbers requesting Fluzone®, Influenza Virus Vaccine for the 2006-2007 season
|
Other Media Centers:
|
||||||
|
Access to categories:
